China Biologic Products Holdings Inc (CBPO.OQ)
71.00USD
19 Oct 2018
$-1.25 (-1.73%)
$72.25
$72.64
$73.54
$70.88
57,975
127,749
$107.32
$70.88
About
Overall
| Beta: | 1.27 |
| Market Cap(Mil.): | $2,897.00 |
| Shares Outstanding(Mil.): | 37.27 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBPO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 119.85 | 32.14 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | 1.96 | 12.83 |
| ROE: | -- | 1.12 | 14.95 |
China Biologic rejects $3.9 billion bid from former CEO
China Biologic Products Holdings Inc rejected a $3.9 billion offer from a consortium led by its former chief executive on Friday and said an affiliate of CITIC Capital had also withdrawn a competing bid.
UPDATE 3-China Biologic rejects $3.9 bln bid from former CEO
* Shares fall 14 pct (Adds former CEO-led consortium's comments)
China Biologic rejects former CEO-led consortium's offer
Aug 24 China Biologic Products Holdings Inc said on Friday it had rejected an offer from a consortium led by its former chief executive and the company said an affiliate of CITIC Capital unit had withdrawn a competing offer.
China Biologic gets $3.9 billion offer from former CEO-led consortium
China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms, valuing the Beijing-based company at slightly above an earlier buyout proposal from a CITIC Capital unit.
UPDATE 2-China Biologic gets $3.9 bln offer from former CEO-led consortium
* A Citic Capital unit offered $110 apiece for the company in June
CORRECTED-UPDATE 1-China Biologic gets $3.9 bln offer from former CEO-led consortium
Aug 20 China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium of investment firms led by the company's former chief executive David Gao.
CORRECTED-China Biologic gets $3.9 bln offer from former CEO-led consortium
Aug 20 China Biologic Products Holdings Inc on Monday received a $3.9 billion all-cash offer from a consortium that included company's former chief executive, GL Capital Group, Bank of China Group Investment Limited and CDH Investments.
Estimates